By: Zaffirini S.B. No. 64
A BILL TO BE ENTITLED
AN ACT
relating to insurance coverage for certain devices that facilitate
insulin therapy and enhance glucose control in the treatment of
diabetes.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subdivisions (1) and (2), Section 1358.051,
Insurance Code, are amended to read as follows:
(1) "Diabetes equipment" means:
(A) blood glucose monitors, including
noninvasive glucose monitors and glucose monitors designed to be
used by blind individuals;
(B) insulin pumps and associated appurtenances;
(C) insulin infusion devices and devices that
facilitate insulin therapy and enhance glucose control; and
(D) podiatric appliances for the prevention of
complications associated with diabetes.
(2) "Diabetes supplies" means:
(A) test strips for blood glucose monitors;
(B) visual reading and urine test strips;
(C) lancets and lancet devices;
(D) insulin and insulin analogs;
(E) injection aids and devices that facilitate
insulin therapy and enhance glucose control;
(F) syringes;
(G) prescriptive and nonprescriptive oral agents
for controlling blood sugar levels; and
(H) glucagon emergency kits.
SECTION 2. This Act applies only to an insurance policy that
is delivered, issued for delivery, or renewed on or after January 1,
2010. A policy delivered, issued for delivery, or renewed before
January 1, 2010, is governed by the law as it existed immediately
before the effective date of this Act, and that law is continued in
effect for that purpose.
SECTION 3. This Act takes effect September 1, 2009.